Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Carbocisteine now in sachets

Manufacturer Intrapharm has made mucolytic carbocisteine available in sachets for the first time.

The 10ml sachets, which launched last week, are a “user-friendly” alternative to the existing capsules and bottled liquid, Intrapharm said. A “main benefit” of taking the drug in its new form is that patients only need three large sachets a day, rather than six capsules or nine teaspoons, it said.

The sachets – which contain 750mg of the drugs –are also 10% less expensive than the capsules and 27% less expensive than the bottled liquid, making them the most cost-effective option for the NHS, the manufacturer claimed.

The drug is indicated for patients over 15 years with recent respiratory disorders, and is usually prescribed to those with chronic obstructive pulmonary disease (COPD), Intrapharm added. A box of 15 sachets has an NHS list price of £3.85.

To order, contact distributor Movianto on 01234 248632

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD007688

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel